MARC1, which encodes for mitochondrial amidoxime reducing component 1, is a second gene involved in LD formation that has been implicated by GWAS in ASH and NASH without the benefit of a prior hypothesis (ref. 13). The gene discussed is MTARC1; the disease is metabolic dysfunction-associated steatohepatitis.